Related Experiment Videos
[An active sex life is possible for men undergoing androgen deprivation therapy for prostate cancer]
Mikkel Fode1, Peter Østergren, Christian F S Jensen
1Urologisk Afdeling, Roskilde Sygehus, Køgevej 7-13, 4000 Roskilde. mikkelfode@gmail.com.
Abstract:
Sexual function is diminished in the majority of men undergoing androgen deprivation therapy for prostate cancer. However, about 20% seem to retain some degree of libido and erectile function. In addition, the intimacy of sexual relations is important for many couples. Therefore, sexuality should be addressed when patients express an interest in this. In some men, erections can be re-established with normal erectogenic aids. Others will benefit from counselling on alternative sexual practices. The goal should be to make the couple as satisfied as possible with their situation.
Insights
Androgen deprivation therapy for prostate cancer often impacts sexual function, but some men retain libido and erectile function. Addressing sexuality with patients can improve satisfaction through aids or alternative practices.
Area of Science:
- Oncology
- Urology
- Sexual Medicine
Background:
- Androgen deprivation therapy (ADT) is a cornerstone treatment for advanced prostate cancer.
- ADT commonly causes sexual dysfunction, including decreased libido and erectile dysfunction.
- Despite treatment side effects, some patients maintain sexual interest and function.
Purpose of the Study:
- To explore the impact of ADT on male sexual function in prostate cancer patients.
- To identify strategies for managing sexual dysfunction during ADT.
- To enhance sexual satisfaction for couples affected by prostate cancer treatment.
Main Methods:
- Review of existing literature on ADT and sexual function in prostate cancer.
- Analysis of patient-reported outcomes regarding libido and erectile function.
- Evaluation of therapeutic interventions for sexual dysfunction.
Main Results:
- A significant majority of men on ADT experience diminished sexual function.
- Approximately 20% of patients retain some level of sexual desire and erectile capacity.
- Erectogenic aids and counseling on alternative sexual practices can be effective.
Conclusions:
- Sexual function is a critical aspect of quality of life for prostate cancer patients and their partners.
- Proactive discussion and management of sexual health are essential during ADT.
- Tailored interventions can help couples maintain sexual intimacy and satisfaction.